Skip to main content
. 2021 Aug 9;2021:1412663. doi: 10.1155/2021/1412663

Figure 3.

Figure 3

Cumulative risk of change from B1 to B2/B3 in patients with L2 and L3 at diagnosis. B1, nonstricturing, nonpenetrating disease; B2, stricturing disease; B3, penetrating disease; L2, colon location; L3, ileocolon location; 5-ASA, 5-aminosalicylic acid.